HAL will be down for maintenance from Friday, June 10 at 4pm through Monday, June 13 at 9am. More information
Skip to Main content Skip to Navigation
Journal articles

Thiotepa–busulfan–fludarabine (TBF) conditioning regimen in patients undergoing allogeneic hematopoietic cell transplantation for myelofibrosis: an outcome analysis from the Chronic Malignancies Working Party of the EBMT

Giorgia Battipaglia 1, * Katya Mauff 2 Lotus Wendel 2 Emanuele Angelucci 3 Mohamad Mohty 4 William Arcese 5 Stella Santarone Marie-Thérèse Rubio 6, 7 Nicolaus Kroger Maria Laura Fox 8 Didier Blaise 9 Anna Paola Iori 10 Renato Fanin 11 Yves Chalandon 12 Pietro Pioltelli Giuseppe Marotta 13 Patrizia Chiusolo 14, 15 Matjaz Sever 16, 17 Carlos Solano Nathalie Contentin 18 Liesbeth de Wreede 19 Tomasz Czerw 20 Juan Carlos Hernandez-Boluda Patrick Hayden 21 Donal Mclornan 22 Ibrahim Yakoub-Agha 23
Complete list of metadata

https://hal.univ-lorraine.fr/hal-03628347
Contributor : Marie Therese Rubio Connect in order to contact the contributor
Submitted on : Friday, April 1, 2022 - 11:42:04 PM
Last modification on : Sunday, May 15, 2022 - 3:33:33 AM

Identifiers

Citation

Giorgia Battipaglia, Katya Mauff, Lotus Wendel, Emanuele Angelucci, Mohamad Mohty, et al.. Thiotepa–busulfan–fludarabine (TBF) conditioning regimen in patients undergoing allogeneic hematopoietic cell transplantation for myelofibrosis: an outcome analysis from the Chronic Malignancies Working Party of the EBMT. Bone Marrow Transplantation, Nature Publishing Group, 2021, 56 (7), pp.1593-1602. ⟨10.1038/s41409-021-01222-z⟩. ⟨hal-03628347⟩

Share

Metrics

Record views

20